Read more at: Patient stratification in schizophrenia: revisited
Patient stratification in schizophrenia: revisited
9 December 2013
How heterogeneous is the clinical manifestation we refer to as “ schizophrenia ” ? Based on multiplex immuno-assay readings scientists of the CCNR were able to identify two distinct molecular subgroups of antipsychotica naive schizophrenia patients. The implicated clinical potential was validated in an independant cohort...